Literature DB >> 26398619

PrimiOtic and PrimiOtic Plus: novel probiotic for primates suffering from idiopathic chronic diarrhea.

Jaime L Lecker1, Karen Froberg-Fejko1.   

Abstract

Idiopathic chronic diarrhea of nonhuman primates is a major gastrointestinal disorder and a leading cause of serious morbidity in nonhuman primates kept in captivity. Many animals are not responsive to traditional treatments. Millions of dollars are spent annually on diagnosis and supportive care of these animals. Probiotics like Bio-Serv's PrimiOtic and PrimiOtic Plus can help to reduce the incidence of diarrhea in captive nonhuman primates by supporting the natural microflora in the gut.

Entities:  

Mesh：

Year:  2015        PMID： 26398619     DOI： 10.1038/laban.844

Source DB:  PubMed          Journal:  Lab Anim (NY)        ISSN： 0093-7355            Impact factor:   12.625


  8 in total

Review 1.  Safety of probiotics that contain lactobacilli or bifidobacteria.

Authors:  S P Borriello; W P Hammes; W Holzapfel; P Marteau; J Schrezenmeir; M Vaara; V Valtonen
Journal:  Clin Infect Dis       Date:  2003-03-05       Impact factor: 9.079

2.  Evaluation of deficiencies in labeling of commercial probiotics.

Authors:  J Scott Weese
Journal:  Can Vet J       Date:  2003-12       Impact factor: 1.008

Review 3.  Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm.

Authors:  Jens Walter; Robert A Britton; Stefan Roos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-25       Impact factor: 11.205

Review 4.  Role of probiotics in health and disease: a review.

Authors:  Varun Pratap Singh; Jagannath Sharma; Shankar Babu; Anshul Singla
Journal:  J Pak Med Assoc       Date:  2013-02       Impact factor: 0.781

5.  Review article: yeast as probiotics -- Saccharomyces boulardii.

Authors:  D Czerucka; T Piche; P Rampal
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

6.  Diarrhoea. Lactobacillus reuteri reduces episodes of diarrhoea in healthy children.

Authors:  Gillian Patman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-08       Impact factor: 46.802

7.  Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Authors:  Theodoros Kelesidis; Charalabos Pothoulakis
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.802

8.  The evolution of host specialization in the vertebrate gut symbiont Lactobacillus reuteri.

Authors:  Steven A Frese; Andrew K Benson; Gerald W Tannock; Diane M Loach; Jaehyoung Kim; Min Zhang; Phaik Lyn Oh; Nicholas C K Heng; Prabhu B Patil; Nathalie Juge; Donald A Mackenzie; Bruce M Pearson; Alla Lapidus; Eileen Dalin; Hope Tice; Eugene Goltsman; Miriam Land; Loren Hauser; Natalia Ivanova; Nikos C Kyrpides; Jens Walter
Journal:  PLoS Genet       Date:  2011-02-17       Impact factor: 5.917
  8 in total
  2 in total

Review 1.  Engineering the microbiome for animal health and conservation.

Authors:  Se Jin Song; Douglas C Woodhams; Cameron Martino; Celeste Allaband; Andre Mu; Sandrine Javorschi-Miller-Montgomery; Jan S Suchodolski; Rob Knight
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-18

2.  Evaluation of Topical Lysostaphin as a Novel Treatment for Instrumented Rhesus Macaques (Macaca mulatta) Infected with Methicillin-Resistant Staphylococcus aureus.

Authors:  Christopher E Cheleuitte-Nieves; Leslie L Diaz; Maria Pardos de la Gandara; Alejandra Gonzalez; Winrich A Freiwald; Hermínia M de Lencastre; Alexander Tomasz; Chad W Euler
Journal:  Comp Med       Date:  2020-08-13       Impact factor: 0.982
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.